{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:38:17Z","timestamp":1781584697020,"version":"3.54.5"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Designer benzodiazepine (DBZD) use has been increasing over the past decade and poses a threat to human health and safety, particularly when involved in driving under the influence of drug (DUID) cases. Over a 5-year period between 2017 and 2021, there were 1,145 reported DBZDs in 805 blood samples submitted from law enforcement agencies for DUID testing. Eleven different DBZDs were detected, including three metabolite pairs: etizolam\/alpha-hydroxyetizolam, clonazolam\/8-aminoclonazolam, diclazepam\/delorazepam, flualprazolam, flubromazolam, flubromazepam, bromazolam and bromazepam. Etizolam\/alpha-hydroxyetizolam (n\u2009=\u2009485) and flualprazolam (n\u2009=\u2009149) were the most frequently detected DBZDs, at 60% and 18%, respectively. Driving behavior, standardized field sobriety test performance and physical observations of individuals suspected of DUIDs, whose blood sample was toxicologically confirmed for one or more DBZDs, were consistent with the effects caused by central nervous system depressants. Each DBZD has its own unique timeline, and toxicology testing had to be frequently updated to reflect the state of the novel psychoactive substance market. DBZDs play a role in impaired driving and can be the sole intoxicant in DUID cases.<\/jats:p>","DOI":"10.1093\/jat\/bkad036","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T12:44:48Z","timestamp":1687265088000},"page":"668-679","source":"Crossref","is-referenced-by-count":21,"title":["Increasing prevalence of\u00a0designer benzodiazepines in\u00a0impaired driving: A 5-year analysis from 2017 to 2021"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1638-3259","authenticated-orcid":false,"given":"Donna M","family":"Papsun","sequence":"first","affiliation":[{"name":"NMS Laboratories , 200 Welsh Rd, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Chan-Hosokawa","sequence":"additional","affiliation":[{"name":"NMS Laboratories , 200 Welsh Rd, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Lamb","sequence":"additional","affiliation":[{"name":"NMS Laboratories , 200 Welsh Rd, Horsham, PA 19044, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2400-4711","authenticated-orcid":false,"given":"Barry","family":"Logan","sequence":"additional","affiliation":[{"name":"NMS Laboratories , 200 Welsh Rd, Horsham, PA 19044, USA"},{"name":"Center for Forensic Science Research & Education , 2300 Stratford Ave, Willow Grove, PA 19090, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"2023110617123349500_R1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/jat\/bkx082","article-title":"Recommendations for\u00a0toxicological investigation of\u00a0drug-impaired driving and\u00a0motor vehicle fatalities-2017 update","volume":"42","author":"Logan","year":"2018","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jat\/bkab064","article-title":"Recommendations for\u00a0toxicological investigation of\u00a0drug-impaired driving and\u00a0motor vehicle fatalities-2021 update","volume":"45","author":"D\u2019Orazio","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s13181-018-0659-3","article-title":"Assessment of\u00a0the availability, cost, and\u00a0motivations for\u00a0use over time of\u00a0the new psychoactive substances-benzodiazepines diclazepam, flubromazepam, and\u00a0pyrazolam-in the UK","volume":"14","author":"Abouchedid","year":"2018","journal-title":"Journal of Medical Toxicology: Official Journal of the American College of Medical Toxicology"},{"key":"2023110617123349500_R4","first-page":"217","article-title":"The slippery slope of\u00a0flubromazolam: experiences of\u00a0a novel psychoactive benzodiazepine as discussed on\u00a0a Swedish online forum","volume":"34","author":"Andersson","year":"2017","journal-title":"Nordisk Alkohol- & Narkotikatidskrift: NAT"},{"key":"2023110617123349500_R5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s11419-020-00565-4","article-title":"A fluorine turns a medicinal benzodiazepine into NPS: the case of\u00a0flualprazolam","volume":"39","author":"Ntoupa","year":"2021","journal-title":"Forensic Toxicology"},{"key":"2023110617123349500_R6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neuro.2019.02.015","article-title":"An expanding world of\u00a0new psychoactive substances-designer benzodiazepines","volume":"73","author":"Zawilska","year":"2019","journal-title":"Neurotoxicology"},{"key":"2023110617123349500_R7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14060560","article-title":"Designer benzodiazepines: a review of\u00a0toxicology and\u00a0public health risks","volume":"14","author":"Brunetti","year":"2021","journal-title":"Pharmaceuticals"},{"key":"2023110617123349500_R8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/15563650.2018.1506130","article-title":"Occurrence and\u00a0time course of\u00a0NPS benzodiazepines in\u00a0Sweden - results from intoxication cases in\u00a0the STRIDA project","volume":"57","author":"B\u00e4ckberg","year":"2019","journal-title":"Clinical Toxicology"},{"key":"2023110617123349500_R9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/15563650.2018.1510502","article-title":"Designer benzodiazepines: a report of\u00a0exposures recorded in\u00a0the National Poison Data System, 2014-2017","volume":"57","author":"Carpenter","year":"2019","journal-title":"Clinical Toxicology"},{"key":"2023110617123349500_R10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.fsisyn.2021.100138","article-title":"Benzodiazepines reported in\u00a0NFLIS-drug, 2015 to 2018","volume":"3","author":"Bollinger","year":"2021","journal-title":"Forensic Science International Synergy"},{"key":"2023110617123349500_R11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/dta.3119","article-title":"What\u2019s in\u00a0fake \u2018Xanax\u2019?: a dosage survey of\u00a0designer benzodiazepines in\u00a0counterfeit pharmaceutical tablets","volume":"14","author":"Blakey","year":"2022","journal-title":"Drug Testing and Analysis"},{"key":"2023110617123349500_R12","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108300","article-title":"Drug checking identifies counterfeit alprazolam tablets","volume":"218","author":"Tobias","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"key":"2023110617123349500_R13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2021.103409","article-title":"Portable gas chromatography-mass spectrometry in\u00a0drug checking: detection of\u00a0carfentanil and\u00a0etizolam in\u00a0expected opioid samples","volume":"97","author":"Gozdzialski","year":"2021","journal-title":"The International Journal on Drug Policy"},{"key":"2023110617123349500_R14","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2021.103169","article-title":"An outbreak of\u00a0novel psychoactive substance benzodiazepines in\u00a0the unregulated drug supply: preliminary results from a community drug checking program using point-of-care and\u00a0confirmatory methods","volume":"93","author":"Laing","year":"2021","journal-title":"The International Journal on Drug Policy"},{"key":"2023110617123349500_R15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/24734306.2019.1661568","article-title":"Clonazolam: a novel liquid benzodiazepine","volume":"3","author":"Murphy","year":"2019","journal-title":"Toxicology Communications"},{"key":"2023110617123349500_R16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jat\/bkaa050","article-title":"Driving impairment cases involving etizolam and\u00a0flubromazolam","volume":"45","author":"Rohrig","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2019-2953","article-title":"Flualprazolam: report of\u00a0an outbreak of\u00a0a new psychoactive substance in\u00a0adolescents","volume":"146","author":"Blumenberg","year":"2020","journal-title":"Pediatrics"},{"key":"2023110617123349500_R18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/jat\/bkt075","article-title":"Detection of\u00a0phenazepam in\u00a0impaired driving","volume":"37","author":"Kerrigan","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jat\/bks080","article-title":"Phenazepam and\u00a0its effects on\u00a0driving","volume":"37","author":"Stephenson","year":"2013","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.forsciint.2011.05.021","article-title":"Toxicological investigations of\u00a0drivers killed in\u00a0road traffic accidents in\u00a0Norway during 2006-2008","volume":"212","author":"Gjerde","year":"2011","journal-title":"Forensic Science International"},{"key":"2023110617123349500_R21","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.forsciint.2016.09.006","article-title":"Blood concentrations of\u00a0new designer benzodiazepines in\u00a0forensic cases","volume":"268","author":"H\u00f8iseth","year":"2016","journal-title":"Forensic Science International"},{"key":"2023110617123349500_R22","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/jat\/bkaa043","article-title":"Blood concentrations of\u00a0designer benzodiazepines: relation to impairment and\u00a0findings in\u00a0forensic cases","volume":"44","author":"Heide","year":"2020","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R23","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1093\/jat\/bkab105","article-title":"Driving under the influence of\u00a0flualprazolam: 10 case reports","volume":"46","author":"Mercurio","year":"2022","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R24","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1093\/jat\/bkac019","article-title":"Driving impairment cases involving flualprazolam","volume":"46","author":"Youso","year":"2022","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/jat\/bkac012","article-title":"A two-year evaluation of\u00a0flualprazolam concentrations in\u00a0Orange County drivers: effects on\u00a0driving and\u00a0field sobriety test performance","volume":"46","author":"Manaloto","year":"2022","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jat\/bkaa070","article-title":"Flualprazolam blood concentrations in\u00a0197 forensic investigation cases","volume":"45","author":"Papsun","year":"2020","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/jat\/bkab013","article-title":"The development and\u00a0validation of\u00a0a novel designer benzodiazepines panel by LC\u2013MS-MS","volume":"45","author":"Mastrovito","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R28","volume-title":"New Benzodiazepines in Europe - A Review","author":"European Monitoring Centre for Drugs and Drug Addiction.","year":"2021"},{"key":"2023110617123349500_R29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/jat\/bkv122","article-title":"ELISA detection of\u00a0phenazepam, etizolam, pyrazolam, flubromazepam, diclazepam and\u00a0delorazepam in\u00a0blood using Immunalysis\u00ae benzodiazepine kit","volume":"40","author":"O\u2019Connor","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/jat\/bkab110","article-title":"Determination of\u00a0cross-reactivity of\u00a0novel psychoactive substances with drug screen immunoassays kits in\u00a0whole blood","volume":"46","author":"Mastrovito","year":"2022","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11419-016-0338-5","article-title":"Metabolites replace the parent drug in\u00a0the drug arena. The cases of\u00a0fonazepam and\u00a0nifoxipam","volume":"35","author":"Katselou","year":"2017","journal-title":"Forensic Toxicology"},{"key":"2023110617123349500_R32","article-title":"Public Alert Clonazolam","volume-title":"NPS Discovery","author":"Krotulski","year":"2020"},{"key":"2023110617123349500_R33","article-title":"Q1 2023 NPS Scope Recommendations","volume-title":"NPS Discovery","author":"Krotulski"},{"key":"2023110617123349500_R34","doi-asserted-by":"crossref","first-page":"e4","DOI":"10.1093\/jat\/bkaa146","article-title":"A case series of\u00a0etizolam in\u00a0opioid-related deaths","volume":"45","author":"Gevorkyan","year":"2021","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.forsciint.2019.110101","article-title":"Femoral blood concentrations of flualprazolam in\u00a033 postmortem cases","volume":"307","author":"Kriikku","year":"2020","journal-title":"Forensic Science International"},{"key":"2023110617123349500_R36","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.111140","article-title":"Characteristics of\u00a0fatal \u2018novel\u2019 benzodiazepine toxicity in\u00a0Australia","volume":"331","author":"Darke","year":"2022","journal-title":"Forensic Science International"},{"key":"2023110617123349500_R37","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.15585\/mmwr.mm7034a2","article-title":"Trends in\u00a0nonfatal and\u00a0fatal overdoses involving benzodiazepines - 38 states and\u00a0the District of\u00a0Columbia, 2019-2020","volume":"70","author":"Liu","year":"2021","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"key":"2023110617123349500_R38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/jat\/bkab106","article-title":"Etizolam blood concentrations in\u00a0191 forensic cases in\u00a0Ontario, Canada (2019\u20132020)","volume":"46","author":"Watts","year":"2022","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.forsciint.2019.02.039","article-title":"A retrospective analysis of\u00a0data from forensic toxicology at the Academy of\u00a0Forensic Science in\u00a02017","volume":"298","author":"Pan","year":"2019","journal-title":"Forensic Science International"},{"key":"2023110617123349500_R40","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2020.110595","article-title":"A comprehensive analytical process, from NPS threat identification to systematic screening: method validation and\u00a0one-year prevalence study","volume":"318","author":"Garneau","year":"2021","journal-title":"Forensic Science International"},{"key":"2023110617123349500_R41","article-title":"Q4 NPS Benzodiazepines Trend Report","volume-title":"NPS Discovery","author":"Krotulski","year":"2022"},{"key":"2023110617123349500_R42","article-title":"Schedules of\u00a0Controlled Substances: Temporary Placement of\u00a0Etizolam, Flualprazolam, Clonazolam, Flubromazolam, and\u00a0Diclazepam in\u00a0Schedule I","author":"Drug Enforcement Administration.","year":"2022"},{"key":"2023110617123349500_R43","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/jat\/bkad005","article-title":"Bromazolam blood concentrations in\u00a0post-mortem cases - a British Columbia perspective","volume":"47","author":"M\u00e9rette","year":"2023","journal-title":"Journal of Analytical Toxicology"},{"key":"2023110617123349500_R44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2021.109244","article-title":"Significant toxicity following an increase in\u00a0poisonings with designer benzodiazepines in\u00a0the Netherlands between 2010 and\u00a02020","volume":"231","author":"Essink","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"key":"2023110617123349500_R45","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3390\/neurolint14030053","article-title":"Novel designer benzodiazepines: comprehensive review of\u00a0evolving clinical and\u00a0adverse effects","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurology International"},{"key":"2023110617123349500_R46","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0269881119901096","article-title":"Designer benzodiazepines\u2019 pharmacological effects and\u00a0potencies: how to find the information","volume":"34","author":"El Balkhi","year":"2020","journal-title":"Journal of Psychopharmacology"},{"key":"2023110617123349500_R47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/17512433.2023.2170349","article-title":"Designer benzodiazepines: an update","volume":"16","author":"Yu","year":"2023","journal-title":"Expert Review of Clinical Pharmacology"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkad036\/50740867\/bkad036.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/47\/8\/668\/52760914\/bkad036.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/47\/8\/668\/52760914\/bkad036.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T17:14:35Z","timestamp":1699290875000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/47\/8\/668\/7203732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":47,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,6,20]]},"published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkad036","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,1]]},"published":{"date-parts":[[2023,6,20]]}}}